These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17706533)

  • 41. FDG PET/CT imaging as a biomarker in lymphoma.
    Meignan M; Itti E; Gallamini A; Younes A
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):623-33. PubMed ID: 25573631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Acta Oncol; 2016; 55(3):386-90. PubMed ID: 25975211
    [No Abstract]   [Full Text] [Related]  

  • 44. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of PET and PET/CT in managing the care of lymphoma patients.
    Evans WC; Gilmore D; English J
    J Nucl Med Technol; 2011 Sep; 39(3):190-4. PubMed ID: 21795369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
    Altamirano J; Esparza JR; de la Garza Salazar J; Calvo PS; Vera SR; Chalapud Revelo JR; Estrada G
    Arch Med Res; 2008 Jan; 39(1):69-77. PubMed ID: 18067998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct comparison of 18F-fluorodeoxyglucose coincidence gamma camera tomography with gallium scanning for the staging of lymphoma.
    Lin P; Chu J; Kneebone A; Moylan E; Jalaludin B; Pocock N; Kiat H; Rosenfeld D
    Intern Med J; 2005 Feb; 35(2):91-6. PubMed ID: 15705137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
    J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. F-18 FDG PET/CT in primary tonsillar lymphoma.
    Zhang MJ; Jiang JJ; Jiang MS; He W
    Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of PET in lymphoma.
    Schwaiger M; Wieder H
    Chang Gung Med J; 2005 May; 28(5):315-25. PubMed ID: 16086546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
    Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller SP; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cheson BD
    J Clin Oncol; 2014 Sep; 32(27):3048-58. PubMed ID: 25113771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
    Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDG PET and PET/CT imaging in lymphoma and melanoma.
    Macapinlac HA
    Cancer J; 2004; 10(4):262-70. PubMed ID: 15383207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?
    Shankar A; Fiumara F; Pinkerton R
    Eur J Cancer; 2008 Mar; 44(5):663-73. PubMed ID: 18313916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorine-18-fluorodeoxyglucose positron emission tomography metabolic imaging in patients with lymphoma.
    Huić D; Dodig D
    Croat Med J; 2002 Oct; 43(5):541-5. PubMed ID: 12402392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis].
    Ramos-Font C; Rebollo Aguirre AC; Villegas Portero R; Romero Tabares A; Gallego Peinado M; Llamas Elvira JM
    Rev Esp Med Nucl; 2009; 28(2):48-55. PubMed ID: 19406048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.